USNA · Usana Health Sciences Inc · Documents
$14.07
+0.03 (+0.21%)
At close · Oct 27
Return incl. dividend (before tax)
Q2 2026 earnings call transcript
Market Cap
$262.92M
Shares
18.48M
Volume · Oct 27
136.81K
Avg daily vol (3M)
205.85K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | Usana Health Sciences Inc amended its $75,000,000 revolving credit facility, which matures June 27, 2030, requiring trailing four-quarter Consolidated EBITDA of at least $100,000,000, or $70,000,000 when Revolving Exposure is $50,000,000 or less. | 2026-10-05 | — | |
| 10-Q | — | 2026-08-13 | 2026-07-04 | |
| 8-K | — | 2026-08-04 | — | |
| 8-K | — | 2026-05-20 | — | |
| Investor Event Transcript | — | 2026-05-20 | 2026-06-30 | |
| 10-Q | — | 2026-05-12 | 2026-04-04 | |
| 8-K | — | 2026-05-05 | — | |
| ARS | — | 2026-04-07 | 2026-01-03 | |
| DEF 14A | — | 2026-04-07 | 2026-01-03 | |
| 10-K | — | 2026-03-16 | 2026-01-03 | |
| 8-K | — | 2026-02-18 | 2026-02-17 | |
| 8-K/A | — | 2026-02-11 | — | |
| 8-K | — | 2026-01-12 | — | |
| 8-K | — | 2026-01-08 | — | |
| 10-Q | — | 2025-11-05 | 2025-09-27 | |
| 8-K | — | 2025-10-22 | — | |
| 8-K | — | 2025-10-09 | — | |
| 10-Q | — | 2025-08-05 | 2025-06-28 | |
| 8-K | — | 2025-07-22 | — | |
| 8-K | — | 2025-07-01 | 2025-06-27 | |
| 8-K | — | 2025-05-20 | 2025-05-19 | |
| 10-Q | — | 2025-05-06 | 2025-03-29 | |
| DEFA14A | — | 2025-05-01 | — | |
| 8-K | — | 2025-04-22 | — | |
| DEFA14A | — | 2025-04-16 | — | |
| ARS | — | 2025-04-09 | 2024-12-28 | |
| DEFA14A | — | 2025-04-09 | — | |
| DEF 14A | — | 2025-04-04 | 2024-12-28 | |
| 10-K | — | 2025-03-12 | 2024-12-28 | |
| 8-K/A | — | 2025-03-07 | 2024-12-23 | |
| 8-K | — | 2025-02-25 | — | |
| 8-K | — | 2024-12-23 | — | |
| 10-Q | — | 2024-11-05 | 2024-09-28 | |
| 8-K | — | 2024-10-22 | — | |
| 10-Q | — | 2024-08-06 | 2024-06-29 | |
| 8-K | — | 2024-07-23 | — | |
| 10-Q | — | 2024-05-07 | 2024-03-30 | |
| 8-K | — | 2024-05-07 | 2024-05-06 | |
| 8-K | — | 2024-04-30 | — | |
| DEFA14A | — | 2024-03-27 | — | |
| ARS | — | 2024-03-27 | 2023-12-30 | |
| DEF 14A | — | 2024-03-22 | 2023-12-30 | |
| 10-K | — | 2024-02-27 | 2023-12-30 | |
| 8-K | — | 2024-02-06 | — | |
| 10-Q | — | 2023-11-07 | 2023-09-30 | |
| 8-K | — | 2023-10-24 | — | |
| 10-Q | — | 2023-08-08 | 2023-07-01 | |
| 8-K | — | 2023-07-25 | — | |
| 8-K/A | — | 2023-05-12 | 2023-05-10 | |
| 8-K | — | 2023-05-11 | 2023-05-10 |
Showing 1–50 of 105 filings
Key facts
CIK
896264
CUSIP
90328M107
13F (30d)
19 filings
19 filers
Visit website
Investor relations